Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamouda Boussen

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Journal of Global Oncology|October 29, 2019
OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell CarcinomaMarwan Ghosn, Roland Eid, Emad Hamada, et al.
Biomed Research International|August 29, 2013
Further evidence of mutational heterogeneity of the XPC gene in Tunisian families: a spectrum of private and ethnic specific mutationsMariem Ben Rekaya, Manel Jerbi, Olfa Messaoud, et al.
Plos One|January 27, 2021
Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in TunisiaMaroua Boujemaa, Yosr Hamdi, Nesrine Mejri, et al.
Biomed Research International|May 31, 2014
A founder large deletion mutation in Xeroderma pigmentosum-Variant form in Tunisia: implication for molecular diagnosis and therapyMariem Ben Rekaya, Nadia Laroussi, Olfa Messaoud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2008
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapyStephen Johnston, Maureen Trudeau, Bella Kaufman, et al.
Oncotarget|December 24, 2016
MARCKS protein overexpression in inflammatory breast cancerMaroua Manai, Jeanne Thomassin-Piana, Amor Gamoudi, et al.
Journal of Translational Medicine|June 9, 2018
Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer casesYosr Hamdi, Maroua Boujemaa, Mariem Ben Rekaya, et al.
Frontiers in Genetics|November 26, 2020
Identification of Novel <i>BRCA1</i> and <i>RAD50</i> Mutations Associated With Breast Cancer Predisposition in Tunisian PatientsNajah Mighri, Yosr Hamdi, Maroua Boujemaa, et al.
Frontiers in Genetics|February 5, 2024
Uncovering the clinical relevance of unclassified variants in DNA repair genes: a focus on <i>BRCA</i> negative Tunisian cancer familiesMaroua Boujemaa, Fatma Nouira, Nouha Jandoubi, et al.
Frontiers in Genetics|August 30, 2021
Identification of <i>BRCA2 Cis</i> Double Heterozygous Breast Cancer Cases Using Whole Exome Sequencing: Phenotypic Expression and Impact on Personalized OncologyYosr Hamdi, Maroua Boujemaa, Najah Mighri, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Journal of Global Oncology|October 29, 2019
OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell CarcinomaMarwan Ghosn, Roland Eid, Emad Hamada, et al.
Biomed Research International|August 29, 2013
Further evidence of mutational heterogeneity of the XPC gene in Tunisian families: a spectrum of private and ethnic specific mutationsMariem Ben Rekaya, Manel Jerbi, Olfa Messaoud, et al.
Plos One|January 27, 2021
Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in TunisiaMaroua Boujemaa, Yosr Hamdi, Nesrine Mejri, et al.
Biomed Research International|May 31, 2014
A founder large deletion mutation in Xeroderma pigmentosum-Variant form in Tunisia: implication for molecular diagnosis and therapyMariem Ben Rekaya, Nadia Laroussi, Olfa Messaoud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2008
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapyStephen Johnston, Maureen Trudeau, Bella Kaufman, et al.
Oncotarget|December 24, 2016
MARCKS protein overexpression in inflammatory breast cancerMaroua Manai, Jeanne Thomassin-Piana, Amor Gamoudi, et al.
Journal of Translational Medicine|June 9, 2018
Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer casesYosr Hamdi, Maroua Boujemaa, Mariem Ben Rekaya, et al.
Frontiers in Genetics|November 26, 2020
Identification of Novel <i>BRCA1</i> and <i>RAD50</i> Mutations Associated With Breast Cancer Predisposition in Tunisian PatientsNajah Mighri, Yosr Hamdi, Maroua Boujemaa, et al.
Frontiers in Genetics|February 5, 2024
Uncovering the clinical relevance of unclassified variants in DNA repair genes: a focus on <i>BRCA</i> negative Tunisian cancer familiesMaroua Boujemaa, Fatma Nouira, Nouha Jandoubi, et al.
Frontiers in Genetics|August 30, 2021
Identification of <i>BRCA2 Cis</i> Double Heterozygous Breast Cancer Cases Using Whole Exome Sequencing: Phenotypic Expression and Impact on Personalized OncologyYosr Hamdi, Maroua Boujemaa, Najah Mighri, et al.
Pageof 11